medigraphic.com
Instituto Nacional de Salud Pública

2007, Number 6

<< Back Next >>

salud publica mex 2007; 49 (6)

Basic knowledge of risks for non-opioid analgesics (NOA) in ambulatory patients.

Vladislavovna DS, Mino-León D, Torres-Arreola LP, Romero-Quechol G

Language: Spanish
References: 26
Page: 429-436
PDF size: 179.55 Kb.


ABSTRACT

Objective. To describe patients’ knowledge of non-opioid analgesics (NOA) and to identify factors associated with patients’ lack of basic knowledge (LBN) on this type of medication. Material and Methods. A total of 629 ambulatory patients older than 50 years of age, with non-malignant pain syndrome, attended to two family medicine clinics and received seven day prescriptions for NOA. The data on patients’ general characteristics, the information they received and their actual knowledge of NOA were analyzed using descriptive statistics and bivariate analysis. Results. A total of 64.2% had LBN; 28% did not know how to take NOA properly, and 48% knew that these drugs cause gastrointestinal adverse effects. The factors significantly associated with LBN on NOA included: failure to receive information on NOA (OR:2.22, 95%CI 1.32-3.70), education ‹7 years (OR:1.87, 95%CI 1.33- 2.63) and pain duration <4 years (OR:1.70, 95%CI 1.22-2.37). Conclusion. Patients lack knowledge and receive little information on NOA. It is important to encourage actions to tackle this problem.


REFERENCES

  1. Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drugrelated hospital admissions. Ann Pharmacother 2002;36:1238-1248.

  2. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-147.

  3. Pirmohamed M, James S, Meakin S, Green C, Scout AK, Walley TJ, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-19.

  4. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-1116.

  5. Busson M, Dunn APM. Patients knowledge about prescribed medicines. Pharmaceutical Journal 1986;236:624-626.

  6. O´Connell MB, Jonson JF. Evaluation of medication knowledge in elderly patients. Ann Pharmacother 1992;26:919-921.

  7. Enlund H, Vainio K, Wallenius S, Poston JW. Adverse drug effects and the need for drug information. Med Care 1991;29:558-564.

  8. Laine C, Davidoff F, Lewis CE, Nelson EC, Nelson E, Kessler RC, et al. Important elements of outpatient care: a comparison of patients and physicians opinions. Ann Intern Med 1996;125:640-645.

  9. Ridout S, Waters WE, George CF. Knowledge of and attitudes to medicines in the Southampton community. Br J Clin Pharmacol 1086;21:701-712.

  10. Gibbs S, Waters WE, George CF. Communicating information to patients about medicine. J R Soc Med 1990;83;292-297.

  11. WHO:EDM-18. Public education in drug use: a growing need. Disponible en: http://mednet2.who.int/edmonitor/edition/edm18a.html

  12. De Young M. Research on the effects of pharmacist-patient communication in institutions and ambulatory care sites, 1969-1994. Am J Health Syst Pharm 1996;53:1277-1291.

  13. Tang PC, Newcomb C. Informing patients: a guide for providing patient health information. J Am Med Inform Assoc 1998; 5:563-570.

  14. O’Neil CK, Poirer TI. Impact of patient knowledge, patientpharmacist relationship, and drug perceptions on adverse drug therapy outcomes. Pharmacotherapy 1998;18:333-340.

  15. Keys J, Beardon PH, Lau CC, McDevitt DG. General practitioners use of mom-steroidal anti-inflammatory drugs in Tayside and fife regions. J R Soc Med 1992;117:684-689.

  16. Tamblyn R, Berkson L, Dauphinee WD, Gayton D, Grad R, Huang A, et al. Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice. Ann Intern Med 1997; 127:429-438.

  17. Hill J, Bird H. Patient knowledge and misconceptions of osteoarthritis assessed by a validated self-completed knowledge questionnaire (PKQ-OA). Rheumatology 2007;46:796-800.

  18. Instituto Mexicano del Seguro Social. Información estadística en salud. Consultas de Medicina Familiar. Primera Vez 2006. Disponible en: http://www.imss.gob.mx/dpm/dties/Celula.aspx?ID=SC06_00_00_01_06&OPC=opc07&SRV=A2006

  19. Vallerand AH, Fouladbakhsh J, Templin T. Patients choices for the selftreatment of pain. Appl Nurs Res 2005;18:90-96.

  20. WHO Collaborating Centre for International drug monitoring. Viewpoint part 1. Uppsala, Sweden: The Uppsala Monitoring Centre,2003.

  21. Ascione FJ, Kirscht JP, Shimp LA. An assessment of different components of patient medication knowledge. Med Care 1986;24:1018-1028.

  22. McMahon T, Clark CM, Bailie GR. Who provides patients with drug information ? BMJ 1987;294:355-356.

  23. Morris LA, Grossman R, Barkdol GL, Gordon E, Soviero C. A survey of patients sources of prescription drug information. AJPH 1984;74: 1161-1162.

  24. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule. Fed Regist 1980;45(179 Pt 2):60754-60784.

  25. Rubio Terrés C. La regulación de los medicamentos en España. Med Clin 1992;98:741-748.

  26. Grime J, Blenkinsopp A, Raynor DK, Pollock K, Knapp P. The role and value of written information for patients about individual medicines: a systematic review. Health Expect 2007;10:286-298.




2020     |     www.medigraphic.com